Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2021-07-29 00:00:00 ET · period of report 2021-07-28 · accession 0001209191-21-048494 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-07-29 | 2021-07-28 | TVTX | Rosenberg Noah L. | Chief Medical Off | S - Sale | $13.81 | -1,250 | 44.5K | -3% | -$17.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-28 | S | D | 1,250 | $13.81 | 44,521 | D | — | — | (F2) Includes 177 shares of the Issuer's common stock acquired by the reporting person on May 31, 2021 pursuant to an employee stock purchase program. |